HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Radiotherapy in patients with vestibular schwannoma and neurofibromatosis type 2: clinical results and review of the literature.

AbstractAIMS AND BACKGROUND:
To evaluate the long-term outcome of patients with vestibular schwannoma (VS) and neurofibromatosis type 2 (NF2) treated with fractionated stereotactic radiotherapy (FSRT) or stereotactic radiosurgery (SRS).
PATIENTS AND METHODS:
Sixteen VS in 14 patients with NF2 were treated with FSRT (n = 14) and SRS (n = 2). Patients with tumor progression and/or progression of clinical symptoms were selected for treatment. For patients treated with FSRT a median total dose of 57.6 Gy was prescribed with a median fractionation of 5 × 1.8 Gy per week. For patients who underwent SRS a median single dose of 17 Gy was prescribed to the 80% isodose.
RESULTS:
FSRT and SRS were well tolerated. Local control rate was 94% for a median follow-up time of 131 months; 2- and 5-year progression-free survival were 100%. The probability of maintaining the pretreatment hearing level was 44%. Useful hearing preservation was 33%. Cranial nerve toxicity was moderate. Trigeminal nerve function worsened in 2 patients (12%) and facial nerve function in 3 patients (19%). One patient developed a new tinnitus.
CONCLUSION:
FSRT and SRS are both safe and effective noninvasive and minimally invasive treatment options for patients with VS in the setting of NF2. The long-term local control rates are excellent. Functional hearing preservation is worse in patients with VS and NF2 than in patients with sporadic VS.
AuthorsJohanna Wagner, Thomas Welzel, Daniel Habermehl, Jürgen Debus, Stephanie E Combs
JournalTumori (Tumori) 2014 Mar-Apr Vol. 100 Issue 2 Pg. 189-94 ISSN: 2038-2529 [Electronic] United States
PMID24852864 (Publication Type: Journal Article)
Topics
  • Adult
  • Disease-Free Survival
  • Dose Fractionation, Radiation
  • Facial Nerve (physiopathology, radiation effects)
  • Female
  • Follow-Up Studies
  • Hearing
  • Hearing Loss (etiology)
  • Humans
  • Male
  • Middle Aged
  • Neurofibromatosis 2 (complications, physiopathology, surgery)
  • Neuroma, Acoustic (complications, physiopathology, surgery)
  • Radiosurgery (methods)
  • Tinnitus (etiology)
  • Treatment Outcome
  • Trigeminal Nerve (physiopathology, radiation effects)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: